Celtaxsys Announces Last Patient, Last Visit in Landmark CF Phase 2b Lung Function Preservation Tria
ATLANTA, May 17, 2018 (GLOBE NEWSWIRE) -- Celtaxsys, Inc., a clinical stage pharmaceutical development company focused on advancing...


Toothpaste ingredient may bust up cystic fibrosis biofilms
A common antibacterial substance in toothpaste may combat life-threatening diseases such as cystic fibrosis when combined with an with an...


Improving Antibiotic Strategies To Combat Respiratory Infections In Cystic Fibrosis Patients
Cystic fibrosis (CF) is an inherited, progressive disease caused by mutations in the cystic fibrosis transmembrane regulator (CFTR)...


CFF ‘Venture Philanthropy’ Model Crucial to CF Breakthroughs and Group’s Success, CEO Says
When the Cystic Fibrosis Foundation (CFF) was established in 1955, most people with cystic fibrosis (CF) didn’t make it to their sixth...


Carlow Cystic Fibrosis sufferer welcoming news that Orkambi will be available for children
A local Cystic Fibrosis sufferer says news that the drug Orkambi will now be available to children is fantastic. The Department of Health...


Myoepithelial Cells Are Reserve Stem Cells For Lung Airway Repair
A new population of stem cells that appear to be important for regenerating the airway following severe injury has been identified by...


Vertex Announces VX-445 Phase 3 Trial Program, Positive Data on VX-561 Combo Regimen
Vertex Pharmaceuticals is launching Phase 3 clinical trials to evaluate the safety and effectiveness of its investigational therapy,...


Galapagos to Start Trial Testing New Triple-Combo Therapy for CF
Galapagos is starting a clinical trial called FALCON to evaluate a new triple-combination therapy to treat cystic fibrosis patients. The...


True Health Launches New Genetic Carrier Screening
FRISCO, Texas, April 16, 2018 /PRNewswire/ -- True Health announced today that it will introduce new testing options for patients...
NuvoAir Launches Air Next, Revolutionary New Home Device to Help Those With Serious Lung Conditions
STOCKHOLM, April 18, 2018 /PRNewswire/ -- The latest version of a hand-held device to help people improve the self-management of ongoing...






































